Nomura Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2M | Buy |
151,315
+1,196
| +0.8% | +$79.7K | 0.02% | 461 |
|
|
2026
Q1 | $9.43M | Buy |
150,119
+6,100
| +4% | +$425K | 0.02% | 455 |
|
|
2025
Q4 | $9.56M | Buy |
144,019
+3,040
| +2% | +$197K | 0.02% | 447 |
|
|
2025
Q3 | $9.49M | Sell |
140,979
-18,931
| -12% | -$1.5M | 0.02% | 446 |
|
|
2025
Q2 | $14M | Buy |
159,910
+4,568
| +3% | +$358K | 0.04% | 365 |
|
|
2025
Q1 | $10.6M | Buy |
155,342
+5,866
| +4% | +$479K | 0.03% | 404 |
|
|
2024
Q4 | $11.6M | Sell |
149,476
-4,705
| -3% | -$348K | 0.04% | 372 |
|
|
2024
Q3 | $10.3M | Sell |
154,181
-45,487
| -23% | -$3.74M | 0.03% | 399 |
|
|
2024
Q2 | $22.6M | Buy |
199,668
+13,828
| +7% | +$1.75M | 0.08% | 235 |
|
|
2024
Q1 | $25.8M | Buy |
185,840
+4,632
| +3% | +$582K | 0.09% | 221 |
|
|
2023
Q4 | $22.5M | Sell |
181,208
-31,303
| -15% | -$3.2M | 0.09% | 229 |
|
|
2023
Q3 | $19.8M | Buy |
212,511
+21,033
| +11% | +$2.37M | 0.09% | 240 |
|
|
2023
Q2 | $24.6M | Buy |
191,478
+7,022
| +4% | +$849K | 0.11% | 214 |
|
|
2023
Q1 | $21.4M | Buy |
184,456
+8,138
| +5% | +$911K | 0.11% | 214 |
|
|
2022
Q4 | $20M | Buy |
176,318
+2,549
| +1% | +$280K | 0.12% | 200 |
|
|
2022
Q3 | $14M | Sell |
173,769
-4,294
| -2% | -$364K | 0.09% | 252 |
|
|
2022
Q2 | $13.3M | Buy |
178,063
+27,759
| +18% | +$2.53M | 0.08% | 257 |
|
|
2022
Q1 | $19.2M | Sell |
150,304
-6,448
| -4% | -$705K | 0.1% | 207 |
|
|
2021
Q4 | $21M | Buy |
156,752
+71,572
| +84% | +$10.3M | 0.11% | 191 |
|
|
2021
Q3 | $11.6M | Sell |
85,180
-8,400
| -9% | -$1.06M | 0.07% | 282 |
|
|
2021
Q2 | $9.99M | Buy |
93,580
+6,880
| +8% | +$661K | 0.06% | 311 |
|
|
2021
Q1 | $7.79M | Buy |
86,700
+1,484
| +2% | +$139K | 0.05% | 348 |
|
|
2020
Q4 | $7.88M | Buy |
85,216
+5,520
| +7% | +$493K | 0.05% | 313 |
|
|
2020
Q3 | $8.21M | Buy |
79,696
+3,836
| +5% | +$401K | 0.06% | 272 |
|
|
2020
Q2 | $7.69M | Buy |
75,860
+13,300
| +21% | +$1.19M | 0.07% | 266 |
|
|
2020
Q1 | $4.21M | Buy |
62,560
+6,040
| +11% | +$376K | 0.04% | 341 |
|
|
2019
Q4 | $3.09M | Buy |
56,520
+160
| +0.3% | +$7.59K | 0.03% | 469 |
|
|
2019
Q3 | $2.1M | Buy |
56,360
+1,360
| +2% | +$52.8K | 0.02% | 566 |
|
|
2019
Q2 | $2.06M | Buy |
55,000
+5,200
| +10% | +$163K | 0.02% | 568 |
|
|
2019
Q1 | $1.48M | Hold |
49,800
| – | – | 0.01% | 667 |
|
|
2018
Q4 | $1.49M | Buy |
+49,800
| New | +$1.58M | 0.02% | 597 |
|
|
2017
Q4 | – | Sell |
-43,600
| Closed | -$533K | – | 935 |
|
|
2017
Q3 | $533K | Buy |
43,600
+6,000
| +16% | +$106K | 0.01% | 813 |
|
|
2017
Q2 | $688K | Buy |
37,600
+400
| +1% | +$7.39K | 0.01% | 777 |
|
|
2017
Q1 | $788K | Hold |
37,200
| – | – | 0.01% | 744 |
|
|
2016
Q4 | $555K | Buy |
+37,200
| New | +$659K | 0.01% | 807 |
|
Other funds holding DXCM
Nomura Asset Management's DXCM Position: Q2 2026 in Review
Nomura Asset Management increased its DexCom (DXCM) stake by 0.8% in Q2 2026, buying an estimated $79.7K and bringing the position to 151,315 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #461.
Nomura Asset Management first reported a position in DXCM in Q4 2016 and has held it in 35 quarters since. The position peaked at $25.8M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Nomura Asset Management held 151,315 shares of DexCom worth $10.2M as of Q2 2026.
- Nomura Asset Management bought 1,196 DexCom shares in Q2 2026, an estimated $79.7K.
- DexCom made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #461 holding.
- Nomura Asset Management first reported a position in DexCom in Q4 2016 and has held it in 35 quarters since.
- Nomura Asset Management's DexCom position peaked at $25.8M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.